Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-Blind Placebo-Controlled Parallel Group Study of the Efficacy and Safety of XRP0038/NV1FGF on Amputation or Any Death in Critical Limb Ischemia Patients With Skin Lesions

NCT00566657 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00566657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00566657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-Blind Placebo-Controlled Parallel Group Study of the Efficacy and Safety of XRP0038/NV1FGF on Amputation or Any Death in Critical Limb Ischemia Patients With Skin Lesions
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2007
Completion date
August 31, 2012
Enrollment
525 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral vascular diseases